Beneficial Proapoptotic Effect of Heterobasidion Annosum Extract in Colorectal Cancer Xenograft Mouse Model
Molecules · 2023
DOI: 10.3390/molecules28031352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Anna Sadowska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bialystok University of Technology, Medical University of Białystok, Medical University of Bialystok.
Abstract (Originalsprache)
Fungal extracts possess potential anticancer activity against many malignant neoplastic diseases. In this research, we focused on the evaluation of Heterobasidion annosum (HA) extract in colorectal cancer in an in vivo model. The mice with implanted DLD-1 human cancer cells were given HA extract, the referential drug—5-fluorouracil (5FU), or were treated with its combination. Thereafter, tumor volume was measured and apoptotic proteins such as caspase-8, caspase-3, p53, Bcl-2, and survivin were analyzed in mice serum with an ELISA assay. The Ki-67 protein was assessed in tumor cells by immunohistochemical examination. The biggest volumes of tumors were confirmed in the DLD-1 group, while the lowest were observed in the population treated with 5FU and/or HA extract. The assessment of apoptosis showed increased concentrations of caspase 8 and p53 protein after the combined administration of 5FU and HA extract. The levels of survivin and Bcl-2 were decreased in all tested groups compared to the DLD-1 group. Moreover, we observed a positive reaction for Ki-67 protein in all tested groups. Our findings confirm the apoptotic effect of extract given alone or with 5FU. The obtained results are innovative and provide a basis for further research concerning the antitumor activity of the HA extract, especially in the range of its interaction with an anticancer chemotherapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Pharmacology, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland.
- Department of Haematology, Medical University of Bialystok, M. Skłodowskiej-Curie 24A, 15-276 Bialystok, Poland.
- Department of General Pathomorphology, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
- Department of Silviculture and Forest Use, Institute of Forest Sciences, Bialystok University of Technology, Wiejska 45E, 15-351 Bialystok, Poland.
ORCID-Profile: Anna Sadowska, Diana Sawicka, Ewa Zapora, Emilia Sokołowska
Förderung
- Bialystok University of Technology
- Medical University of Białystok
- Medical University of Bialystok
Zitieren
APA
Sadowska, A., Sawicka, D., Godlewska, K., Guzińska-Ustymowicz, K., Zapora, E., Sokołowska, E., & Car, H. (2023). Beneficial Proapoptotic Effect of Heterobasidion Annosum Extract in Colorectal Cancer Xenograft Mouse Model. Molecules. https://doi.org/10.3390/molecules28031352
Vancouver
Sadowska A, Sawicka D, Godlewska K, Guzińska-Ustymowicz K, Zapora E, Sokołowska E, et al. Beneficial Proapoptotic Effect of Heterobasidion Annosum Extract in Colorectal Cancer Xenograft Mouse Model. Molecules. 2023. doi:10.3390/molecules28031352
BibTeX
@article{Sadowska2023,
author = {Sadowska, Anna and Sawicka, Diana and Godlewska, Katarzyna and Guzińska-Ustymowicz, Katarzyna and Zapora, Ewa and Sokołowska, Emilia and Car, Halina},
title = {Beneficial Proapoptotic Effect of Heterobasidion Annosum Extract in Colorectal Cancer Xenograft Mouse Model},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28031352}
}
EUVIMED